Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Avadel Pharmaceuticals plc’s stock clocked out at $10.50, down -0.33% from its previous closing price of $10.53. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 0.69 million shares were traded. AVDL stock price reached its highest trading level at $10.67 during the session, while it also had its lowest trading level at $10.3.
Ratios:
To gain a deeper understanding of AVDL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.97. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 12, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 05, 2024, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $27 to $29.
Needham reiterated its Buy rating for the stock on March 05, 2024, while the target price for the stock was revised from $20 to $22.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when MCHUGH THOMAS S bought 2,300 shares for $10.44 per share. The transaction valued at 24,019 led to the insider holds 87,800 shares of the business.
MCHUGH THOMAS S bought 5,000 shares of AVDL for $52,432 on Dec 11 ’24. The Chief Financial Officer now owns 85,500 shares after completing the transaction at $10.49 per share. On Dec 06 ’24, another insider, Divis Gregory J, who serves as the Chief Executive Officer of the company, bought 9,598 shares for $9.98 each. As a result, the insider paid 95,759 and bolstered with 9,598 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1011795776 and an Enterprise Value of 984243072. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.32 while its Price-to-Book (P/B) ratio in mrq is 13.55. Its current Enterprise Value per Revenue stands at 7.124 whereas that against EBITDA is -15.873.
Stock Price History:
Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $9.41. The 50-Day Moving Average of the stock is -12.07%, while the 200-Day Moving Average is calculated to be -28.41%.
Shares Statistics:
It appears that AVDL traded 1.18M shares on average per day over the past three months and 836830 shares per day over the past ten days. A total of 96.34M shares are outstanding, with a floating share count of 88.14M. Insiders hold about 8.53% of the company’s shares, while institutions hold 74.83% stake in the company. Shares short for AVDL as of 1734048000 were 11527683 with a Short Ratio of 9.75, compared to 1731628800 on 8814536. Therefore, it implies a Short% of Shares Outstanding of 11527683 and a Short% of Float of 13.68.
